Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
Is Wellness Tourism the Next Big Reason to Travel?
Greg O'Hara CEO at Certares joined Cheddar to discuss his personal experience with Wellness Tourism and his predictions for the future of the growing industry.
Are Trump's Cabinet Picks Moving the Markets?
Jacob Sonenshine, stock pick writer at Barron's, joins Cheddar to discuss how Trump's win (and cabinet picks) are affecting the stock market. Watch!
Rebecca Minkoff Talks 20 Years Of Fashion
The designer, founder, and 'Real Housewives' star shares what it takes to endure a 20-year career inside the fashion world
Is Now a Good Time to Book A Spirit Flight?
Meghna Maharishi, Airlines Reporter at Skift, answers your biggest questions about what is happening since Spirit Airlines filed for bankruptcy. Watch!
These 3 Minute "Spray-On" Shoes Could Change The Footwear Industry
Popular running shoe brand On's Chief Financial Officer and Co-CEO unveil the company's newest LightSpray technology at On Labs
How the Retail Space is Shaping Up This Holiday Season
Managing Director at Wells Fargo, Adam Davis, joins Cheddar to discuss how both the consumer and retailer are approaching shopping's busiest time of the year.
Big Business This Week: Who’s Gonna Pick Your Fruit?
The economic cost of deporting immigrants. Plus, Elon had another busy week, inflation is complicated, and endless shrimp meets its end.
NBA Commissioner: ‘We Measure Ourselves Against the Biggest Brands’
NBA Commissioner Adam Silver talks Emirates partnership, stance on social media, and why Amazon is the league's next growth opportunity.
Exclusive: NBA Commissioner Says "We Measure Ourselves Against the Biggest Brands in the World"
NBA Commissioner Adam Silver talks Emirates partnership, stance on social media, and why Amazon is the league's next growth opportunity
